Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.878 EUR | +4.81% |
|
+46.78% | +79.37% |
02-05 | Valneva Gets Marketing Authorization in UK for Chikungunya Vaccine; Shares Rise | MT |
02-05 | CAC40: stuck at 7.885, gold breaks record at $2.875/Oz | CF |
Consensus | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
€6.858 | +85.36% | 6 | |||||||
CHF 657.95 | +8.07% | 21 | |||||||
US$247.95 | +23.43% | 23 | |||||||
₩235,952.38 | +31.3% | 21 | |||||||
US$258.12 | +37.77% | 17 | |||||||
US$404.16 | +14.39% | 13 | |||||||
US$62.01 | +100.47% | 22 | |||||||
US$86.96 | +27.24% | 13 | |||||||
US$343.43 | +4.75% | 10 | |||||||
US$58.6 | -17.71% | 10 | |||||||
US$50.68 | +29.03% | 17 | |||||||
US$193.34 | +24.82% | 18 | |||||||
US$73.29 | +76.81% | 14 | |||||||
US$126.05 | +24.1% | 19 | |||||||
A$25.76 | -7.18% | 7 | |||||||
CN¥28.46 | +9.96% | 11 | |||||||
CN¥59.17 | +11.64% | 17 | |||||||
US$34.79 | +8.84% | 14 | |||||||
US$61.32 | +94.17% | 25 | |||||||
Average | 12,564.8 | +30.91% | 16 | ||||||
Weighted average by Cap. | 25,661.58 | +24.73% | 18 |
- Stock Market
- Equities
- VLA Stock
- Sector Valneva
- Sector consensus

MarketScreener is also available in this country: United States.
Switch edition